TRIP Publications

1) Charreau, B. L. Tesson, J.P. Soulillou, C. Pourcel and I. Anegon. Transgenesis in rats: technical aspects and models. Transg. Res. 1996. 5:223-234.
2) Charreau, B. L. Tesson, J. Buscail, J. P. Soulillou and I. Anegon. Analysis of human CD59 tissue expression directed by the CMV-IE-1 promoter in transgenic rats. Transg. Res. 1996. 5:443-450.
3) Charreau, B. L. Tesson, S. Ménoret, J. Buscail, J. P. Soulillou and I. Anegon. Production of transgenic rats for human regulators of complement activation. Transplant. Proc. 1997. 29:1770.
4) Charreau, B. S. Menoret, L. Tesson, J-P. Soulillou, I. Anegon. Generation and use of transgenic rats. Rat Genome. 1997. 3:125-132.
5) Tesson, L. S. Ménoret, B. Charreau, J-P. Soulillou, I. Anegon. Endothelial expression of FasL in transgenic rats under the temporal control of a tetracycline-inducible system. Transplant. Proc. 1999. 31:1533-534.
6) Ménoret, S. B. Charreau, M. Jean, L. Tesson, J-P. Soulillou and I. Anegon. Optimisation of cryopreservation procedures for rat embryos. Transplant. Proc. 1999. 31:1531-1532.
7) Charreau, B. S. Ménoret, L. Tesson, A. Azimzadeh, M. Audet, P. Wolf, R. Marquet, C. Verbakel, J. IJzermans, P. Cowan, M. Pearse, A. d’Apice, J-P. Soulillou, I. Anegon. Protection against hyperacute xenograft rejection of transgenic rat hearts expressing human decay accelerating factor (DAF) transplanted into primates. Mol. Med. 1999. 5:617-630.
8) Verbakel, C.A.E. I. Anegon, S. Ménoret, R.L. Marquet, J.N.M. Ijzermans. Cellular immunity overrules the protective effect of human DAF as demostrated in an ex-vivo heart perfusion model. Transplant. Proc. 2001. 33:781-782.
9) Ménoret, S. M. Jean, L. Tesson, J-P. Soulillou, I. Anegon and B. Charreau. Cryopreservation procedure for 1-cell and two-cell stage transgenic rat embryos. 2001. Transgenics 3:237-242.
10) Laurent Tesson, Jean-Marie Heslan, Séverine Ménoret, and Ignacio Anegon. Rapid and accurate determination of zygosity in transgenic animals by real-time quantitative PCR. 2002. Transg. Res. 11:43-48.
11) Aubert, D. S. Ménoret, D. E. Chiari, V. Pichard, S. Durand, L. Tesson, P. Moullier, I. Anegon and N. Ferry. Cytotoxic immune response blunts long-term transgene expression after efficient retroviral-mediated hepatic gene transfer in rat. 2002. Mol. Ther. 5:388-396.
12) Ménoret, S. D. Aubert, L. Tesson, C. Braudeau, V. Pichard, N. Ferry and I. Anegon. LacZ transgenic rats tolerant for β-galactosidase: recipients for gene transfer studies using lacZ as a reporter gene. 2002. Hum. Gene Ther. 13:1383-1390.
13) D. Bouchet*, L. Tesson*, S. Ménoret, B. Charreau, P. Mathieu, H. Yagita, G. Duisit, and I. Anegon. Differential sensitivity of endothelial cells of various species to apoptosis induced by gene transfer of Fas ligand: role of FLIP levels. 2002. Mol. Med.8:612-23.
14) Stockmann, H. C. Verbakel, P. Okkema, F. Bonthuis, S. Ménoret, I. Anegon, R. Marquet, J. Ijzermans. No functional benefit for hDAF-transgenic rat livers despite protection from tissue damage following perfusion with human serum. Transpl Int. 2002. 15:595-601.
15) Braudeau C, Bouchet D, Toquet C, Tesson L, Ménoret S, Iyer S, Laboisse C, Willis D, Jarry A, Martinet B, Buelow R, Anegon I *and Chauveau C*. Generation of heme oxygenase-1 transgenic rats. 2003. Exp. Biol. Med. 228:466-71.
16) Toumaniantz, G. C. Seze, S. Serpillon, S. Ménoret, L. Tesson, I. Anegon and C. Gauthier. Vascular beta-adrenergic remodeling in rat transgenic model over-expressing endothelial beta 3-adrenoceptors. J Hypertens. 2005. 23:A12
17) Braudeau C, Bouchet D, Toquet C, Tesson L, Ménoret S, Iyer S, Laboisse C, Willis D, Jarry A, Martinet B, Buelow R, Anegon I *+and Chauveau C*. Generation of heme oxygenase-1 transgenic rats. 2003. Exp. Biol. Med. 228:466-71.*both authors shared senior authorship. +corresponding author
18) Laurent Tesson, Jean Cozzi, Séverine Ménoret, Séverine Rémy, Claire Usal, Alexandre Fraichard, Ignacio Anegon. Transgenic modifications of the rat genome. 2005. Transgenic Res. 14:531-46.
19) C. Martin, M. Plat, V. Nerrière-Daguin, F. Coulon, L. Tesson, I. Anegon, B. Melchior, S. Uzbekova, E. Venturi, F. Condé, J-M. Hermel, P. Hantraye, B. Le Mauff, F. Boeffard, S. Sergent-Tanguy, I. Neveu, P. Naveilhan, J-P. Soulillou, M. Terqui, P. Brachet, B. Vanhove. Transgenic expression of CTLA4-Ig by fetal pig neurons for xenotransplantation. 2005. Transgenic Res. 14:373-384.

20) Toumaniantz, G. Seze, C. Serpillon, S. Menoret, S. Tesson, L. Anegon, I. and Gauthier, C. Vascular beta-adrenergic remodeling in rat transgenic model over-expressing endothelial beta3-adrenoceptors. 2005. Arch Mal Coeur Vaiss 98, 836-840.

21) A.M. Geurts G.J. Cost Y. Freyvert B. Zeitler J.C. Miller V.M. Choi S.S. Jenkins A. Wood X. Cui X. Meng A. Vincent S. Lam M. Michalkiewicz R. Schilling J. Foeckler S. Kalloway H. Weiler S. Ménoret I. Anegon G.D. Davis L. Zhang E.J. Rebar P.D. Gregory F.D. Urnov H.J. Jacob & R. Buelow.Knockout rats via embryo microinjection of zinc-finger nucleases 2009. Science. 325 : 433

22) J. Cozzi I. Anegon V. Braun A.C. Gross C. Merrouche & Y. Cherifi. Pronuclear DNA injection for the production of transgenic rats 2009. Methods Mol Biol.. 561 : 73-88
23) S. Tomat F.P. Russo M. Guido G. Kechagias A. Masier C. Calore G. De Silvestro I. Anegon E. Cozzi F. Calabrese & P. Burra. Study of the microcirculation in hDAF transgenic rat livers xenoperfused with human blood 2009. Xenotransplantation. 16 : 83-90
24) S. Ménoret A.-L. Iscache L. Tesson S. Rémy C. Usal M.J. Osborn G.J. Cost M. Brüggemann R. Buelow & I. Anegon.Characterization of immunoglobulin heavy chain knockout rats 2010. Eur. J. Immunol. 40 : 2680-2681
25) S. Rémy L. Tesson C. Usal S. Ménoret V. Bonnamain V. Nerrière-Daguin J. Rossignol C. Boyer T.-H. Nguyen P. Naveilhan L. Lescaudron & I. Anegon.New lines of GFP transgenic rats relevant for regenerative medicine and gene therapy 2010. Transgenic Res. 19 : 745-763
26) S. Rémy L. Tesson S. Ménoret C. Usal A.M. Scharenberg & I. Anegon. Zinc-finger nucleases: a powerful tool for genetic engineering of animals . 2010. Transgenic Res. 19 : 363-371
27) A.M. Geurt G.J. Cost S. Rémy X. Cui L. Tesson C. Usal S. Ménoret H.J. Jacob I. Anegon & R. Buelow.Generation of gene-specific mutated rats using zinc-finger nucleases (technical) 2010. In: Methods in Molecular Biology - Rat Genomics: gene identification, functional genomics and model application. 597 : 211-225
28) L. Tesson S. Rémy S. Ménoret C. Usal & I. Anegon.Analysis by quantitative PCR of zigosity in genetically modified organisms (technical) 2010. In: Methods in Molecular Biology - Rat Genomics. 597 : 277-285
29) S. Ménoret L. Tesson S. Rémy C. Usal A.-L. Iscache & I. Anegon "Transgenesis, recent technical developments" Nantes, 8th June 2009 . 2010. Transgenic Res. 19 : 711-714
30) S. Ménoret S. Rémy C. Usal L. Tesson & I. Anegon. Generation of transgenic rats by microinjection of short DNA fragments (technical) 2010. In: Methods in Molecular Biology - Rat Genomics. 597 : 81-92
31) S. Rémy T.H. NGuyen S. Ménoret C. Usal L. Tesson & I. Anegon. The use of lentiviral vectors to obtain transgenic rats (technical) 2010. In: Methods in Molecular Biology - Rat Genomics. 597 : 109-125
32) Ménoret S, Tesson L, Remy S, Usal C, Iscache AL, Thynard R, Nguyen TH, Anegon I. 2011. Transgenesis and genome analysis, Nantes, France, June 6th 2011. Transgenic Res.
33) Tesson L, Usal C, Ménoret S, Leung E, Niles BJ, Remy S, Santiago Y, Vincent AI, Meng X, Zhang L, Gregory PD, Anegon I, Cost GJ. 2011. Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol. 2011 ;29(8):695-6.
34) Ménoret S, Remy S, Tesson L., Usal C., Iscache A-L. et I. Anegon. 2011. Generation of Transgenic Rats using Microinjection of Plasmid DNA or Lentiviral vectors. Advanced Protocols for Animal Transgenesis. pp 117-137.
35) Iscache AL, Ménoret S,  Tesson L, Rémy S,  Usal C, Pedros C, Saoudi A, Buelow R  and I Anegon. 2011. Effects of BCL-2 over-expression on B cells in transgenic rats and rat hybridomas.Int Immunol. 23(10):625-36.
36)  Ménoret S, Fontanière S, Jantz D,  Tesson L,  Thinard R, Rémy S,  Usal C, Ouisse LH, Fraichard A, and I Anegon. 2013. Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases. FASEB J. 27 (2): 703-711.
37) Osborn MJ, MA B, Avis S, Binnie A, Dilley J, Yang X, Lindquist K, Ménoret S, Iscache AL, Ouisse LH, Rajpal A, Anegon I, Neuberger MS, Buelow R  and Brüggemann M. 2013. High-Affinity IgG antibodies developp naturally in Ig-Knockout rats germline human IgH/Igk/Igl / loci bearing the rat CH region. J. Immunol. 190 (4): 1481-1490.
38) Ménoret S, Tesson L, Rémy S, Thinard R, Usal C, Ouisse LH, Thepenier V, Anegon I. 2013. Technical advances in the generation of transgenic animals and in their applications. Nantes, France, June 7th 2013. Transgenic Res. 2013 Oct;22(5):1065-72.
39) Ma B, Osborn MJ, Avis S, Ouisse LH, Ménoret S, Anegon I, Buelow R, Brüggemann M. Human antibody expression in transgenic rats: Comparison of chimeric IgH loci with human VH, D and JH but bearing different rat C-gene regions. J Immunol Methods. 2013 Oct 30. doi:pii: S0022-1759(13)00287-1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

TRIP is ISO 9001

TRIP is labelised BioGenOuest

 

TRIP is labellised IBISA

Logo IBISA

TRIP is an SFR Bonamy platform

ITUN  INSERM   CHU de Nantes UNIV NANTES  Pays de la Loire  CNRS  CELPHIDIA 
Copyright (c) TRIP 2014. All rights reserved.